Risks and Benefits of Carnitine Supplementation in Diabetes

被引：20
|
作者：
Dambrova, M. [1 ]
Liepinsh, E. [1 ]
机构：
[1] Latvian Inst Organ Synth, LV-1006 Riga, Latvia
来源：
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 2015年 / 123卷 / 02期
关键词：
L-carnitine; diabetes; food supplement; MUSCLE INSULIN-RESISTANCE; ACTIVATED RECEPTOR-GAMMA; FATTY-ACID OXIDATION; CARDIOVASCULAR-DISEASE; SKELETAL-MUSCLE; PYRUVATE-DEHYDROGENASE; MITOCHONDRIAL-FUNCTION; MYOCARDIAL-INFARCTION; MICROBIOTA METABOLISM; SECONDARY PREVENTION;
D O I：
10.1055/s-0034-1390481
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
L-carnitine is a very popular food supplement due to its safety profile, antioxidant-type activity and suggested effects on energy metabolism pathways. L-carnitine participates in both fatty acid transport pathways and the export of acetyl groups out of the mitochondria. However, contradictory data exist concerning the pharmacological outcomes of L-carnitine treatment in diabetes mellitus, which is a highly prevalent metabolic disease characterised by hyperglycemia and associated with severe complications, including cardiovascular disease and dyslipidemia. Recently, the L-carnitine-derived metabolites, acylcarnitines and trimethylamine-N-oxide, have been associated with increased cardio- metabolic risks. This review aims to highlight the possible risks and benefits of L-carnitine supplementation.
引用
收藏
页码：95 / 100
页数：6
相关论文
共 50 条
  • [41] L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes
    Malaguarnera, Mariano
    Vacante, Marco
    Avitabile, Teresio
    Malaguarnera, Marcella
    Cammalleri, Lisa
    Motta, Massimo
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2009, 89 (01): : 71 - 76
  • [42] Benefits and risks of current pharmacotherapy in the treatment of type 2 diabetes
    Schindler, C.
    Barthel, A.
    Fischer, S.
    Bornstein, S. R.
    Kirch, W.
    [J]. INTERNIST, 2012, 53 (04): : 478 - +
  • [43] Timely commencement of insulin in type 2 diabetes: benefits and risks
    Winkler Gabor
    [J]. ORVOSI HETILAP, 2014, 155 (07) : 255 - 261
  • [44] Benefits and Risks for Intensive Glycemic Control in Patients With Diabetes Mellitus
    Blonde, Lawrence
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 343 (01): : 17 - 20
  • [45] Balancing risks and benefits of bariatric surgery for type 2 diabetes
    Peltonen, Markku
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (06): : 394 - 395
  • [46] Cardiorenal syndrome and iron supplementation—more benefits than risks: a narrative review
    Georgia Doumani
    Georgios Spanos
    Panagiotis Theofilis
    Aikaterini Vordoni
    Rigas G. Kalaitzidis
    [J]. International Urology and Nephrology, 2024, 56 : 597 - 606
  • [47] TREATMENT OF GENETIC CARNITINE DEFICIENCY WITH ORAL CARNITINE SUPPLEMENTATION
    BORUM, PR
    BENNETT, SG
    CHEATHAM, JP
    HAYMOND, MW
    IRIAS, JJ
    MERRITT, RJ
    SCHWENK, WF
    WOLFSDORF, JI
    STORM, MC
    [J]. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1985, 9 (01) : 119 - 119
  • [48] CARNITINE SUPPLEMENTATION IN PIVAMPICILLIN TREATMENT
    MELEGH, B
    [J]. LANCET, 1989, 2 (8671): : 1096 - 1096
  • [49] EFFECT OF CARNITINE SUPPLEMENTATION ON BLOOD CARNITINE PARAMETERS OF NEWBORNS ON TPN
    BORUM, P
    HELMS, R
    HAY, W
    STORM, M
    [J]. CLINICAL RESEARCH, 1987, 35 (03): : A768 - A768
  • [50] Plasma and urine carnitine levels and carnitine supplementation in children with malnutrition
    Alp, H
    Orbak, Z
    Akçay, F
    Tan, H
    Aksoy, H
    [J]. JOURNAL OF TROPICAL PEDIATRICS, 1999, 45 (05) : 294 - 296
12345